
Currently out of the existing stock ratings of Daniil Gataulin, 104 are a BUY (85.95%), 17 are a HOLD (14.05%).
Analyst Daniil Gataulin, currently employed at CHARDAN CAPITAL, has had 32.16% of price targets met with an average potential upside of 55.49%, reached in 136 days on average.
Daniil Gataulin has documented 212 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KOD, Kodiak Sciences at 10-May-2026.
Analyst best performing recommendations are on CRVO (CERVOMED).
The best stock recommendation documented was for CRVO (CERVOMED) on 3/13/2025. The price target of $14 was fulfilled within 8 days with a profit of $8.21 (141.8%), with a performance score of 177.25.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Apr-2024
$5
1 years 1 days ago
(17-Nov-2025)
0/6 (0%)
$0.73 (17.10%)
Buy Since 28-Apr-2020
$5.5
$12
1 years 20 days ago
(29-Oct-2025)
1/8 (12.5%)
$1.27 (30.02%)
366
Hold Since 16-Apr-2025
$4
$5
1 years 21 days ago
(28-Oct-2025)
1/2 (50%)
$-0.26 (-6.10%)
168
Buy Since 18-Jul-2024
1 years 3 months 5 days ago
(13-Aug-2025)
0/2 (0%)
$30.52 (321.94%)
Hold Since 11-Nov-2022
$4
$5
1 years 6 months 3 days ago
(15-May-2025)
4/9 (44.44%)
$1.95 (95.12%)
102
What Year was the first public recommendation made by Daniil Gataulin?